Advanced drug delivery reviews

Adv Drug Deliv Rev · ISSN (e) 1872-8294 · 17 papers in corpus
2024
doi:10.1016/j.addr.2023.115143 ·PMID:38008185

Since the inception of the concept of "magic bullet", nanoparticles have evolved to be one of the most effective carriers in drug delivery. Nanoparticles improve the therapeutic efficacy of drugs offering benefits to treating various diseas…

2024
doi:10.1016/j.addr.2023.115161 ·PMID:38142739

Autoimmune diseases are a diverse and complex set of chronic disorders with a substantial impact on patient quality of life and a significant global healthcare burden. Current approaches to autoimmune disease treatment comprise broadly acti…

2023
doi:10.1016/j.addr.2023.114904 ·PMID:37263542

The global pharmaceutical market has recently shifted its focus from small molecule drugs to peptide, protein, and nucleic acid drugs, which now comprise a majority of the top-selling pharmaceutical products on the market. Although these bi…

2022
doi:10.1016/j.addr.2022.114543 ·PMID:36208729

Vaginal drug delivery systems are often preferred for treating a variety of diseases and conditions of the female reproductive tract (FRT), as delivery can be more targeted with less systemic side effects. However, there are many anatomical…

2022
doi:10.1016/j.addr.2022.114581 ·PMID:36270490

Levonorgestrel intrauterine systems (LNG-IUSs) are complex drug-device combination products designed to release a hormonal contraceptive drug for up to 7 years. These drug delivery systems offers a great promise as a modern method of long-a…

2021
doi:10.1016/j.addr.2020.09.013 ·PMID:33002575

Maternal mortality rates in the United States have steadily increased since 1987 to the current rate of over 16 deaths per 100,000 live births. Whereas most of these deaths are related to an underlying condition, such as cardiovascular dise…

2021
doi:10.1016/j.addr.2021.03.011 ·PMID:33774115

The vast majority of drugs are not designed or developed for pediatric and infant populations. Peptide drugs, which have become increasingly relevant in the past several decades, are no exception. Unfortunately, nearly all of the 60+ approv…

2021
doi:10.1016/j.addr.2021.03.010 ·PMID:33831478

Over the past decade, organs-on-a-chip and microphysiological systems have emerged as a disruptive in vitro technology for biopharmaceutical applications. By enabling new capabilities to engineer physiological living tissues and organ units…

2019
doi:10.1016/j.addr.2019.05.012 ·PMID:31170428

The integration of nuclear imaging with nanomedicine is a powerful tool for efficient development and clinical translation of liposomal drug delivery systems. Furthermore, it may allow highly efficient imaging-guided personalised treatments…

2019
doi:10.1016/j.addr.2019.05.005 ·PMID:31103451

Macrophages are major upstream regulators of the inflammatory response to implanted biomaterials. Sequential functions of distinct macrophage phenotypes are essential to the normal tissue repair process, which ideally results in vasculariza…

2016
doi:10.1016/j.addr.2016.05.020 ·PMID:27262925

Poly(d,l-lactic acid) (PLA) has been widely used for various biomedical applications for its biodegradable, biocompatible, and nontoxic properties. Various methods, such as emulsion, salting out, and precipitation, have been used to make be…

2013
doi:10.1016/j.addr.2012.10.003 ·PMID:23088863

Design and synthesis of efficient drug delivery systems are of vital importance for medicine and healthcare. Materials innovation and nanotechnology have synergistically fueled the advancement of drug delivery. Innovation in material chemis…

review 2009
doi:10.1016/j.addr.2009.04.023 ·PMID:19446586

Gene therapy is the introduction of genetic material into patient's cells to achieve therapeutic benefit. Advances in molecular biology techniques and better understanding of disease pathogenesis have validated the use of a variety of genes…

review 2009
doi:10.1016/j.addr.2009.04.022 ·PMID:19445984

This manuscript serves as a review of Mirena, the levonorgestrel intrauterine system (LNG IUS) as a very successful drug delivery system. The LNG IUS has a very high contraceptive efficacy rate, and low rates of patient discontinuation. In …

2008
doi:10.1016/j.addr.2008.08.001 ·PMID:18848590

Many inner ear disorders cannot be adequately treated by systemic drug delivery. A blood-cochlear barrier exists, similar physiologically to the blood-brain barrier, which limits the concentration and size of molecules able to leave the cir…

other 1997
doi:10.1016/s0169-409x(97)00056-2 ·PMID:10837570

Analogues of luteinizing hormone-releasing hormone (LH-RH) have made possible new approaches to the treatment of some hormone-dependent cancers and diseases and conditions which result from inappropriate sex hormone levels. In the fields of…

article 1997
doi:10.1016/s0169-409x(97)00055-0 ·PMID:10837569

Uterine leiomyomata and endometriosis are two common hormone-dependent pathologies effecting women of reproductive age. Prior to the introduction of gonadotropin releasing hormone agonists (GnRHa), there was no effective medical therapy for…